Targeting rare splicing defects: Antisense oligonucleotides offer a therapeutic strategy in FRDA. [PDF]
Kerkhof LMC, Buijsen RAM.
europepmc +1 more source
Safety and efficacy of individualised exercise and NAD<sup>+</sup> precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial. [PDF]
Lin KY +26 more
europepmc +1 more source
Comparative Structural Analysis of Escherichia Coli Cyay at Room and Cryogenic Temperatures Using Macromolecular and Serial Crystallography. [PDF]
Shafiei A +4 more
europepmc +1 more source
Evaluation of Mitochondrial Complex 1 Density with [<sup>18</sup>F]BCPP-EF in a Murine Model and Individuals with Friedreich Ataxia. [PDF]
Chen L +24 more
europepmc +1 more source
Dimethyl fumarate and mitochondrial physiology: implications for neurological disorders. [PDF]
de Oliveira MR.
europepmc +1 more source
Alpha-lipoic acid supplementation improves pathological alterations in cellular models of Friedreich ataxia. [PDF]
Talaverón-Rey M +12 more
europepmc +1 more source
Polyphenol-Enriched Fraction from Chestnut Shells as a Source of Bioactive Compounds for Friedreich Ataxia. [PDF]
Squillaci G +5 more
europepmc +1 more source
Human pluripotent stem cell models of Friedreich's ataxia: innovations, considerations, and future perspectives. [PDF]
Nguyen HT, Napierala M, Napierala JS.
europepmc +1 more source
The Triple Flexion Response in Friedrich's Ataxia. [PDF]
Saluja A, Sahib A, Yadav V.
europepmc +1 more source
Mitochondrial dysfunction in neurodegenerative disorders: mechanisms and therapeutic advances. [PDF]
Tong Y +11 more
europepmc +1 more source

